Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

Pernilla Wikström, Pär Stattin, Ingela Franck-Lissbrant, Jan‐Erik Damber, Anders Bergh

The Prostate · 1998 · 311 citations · 44 references

Abstract

Overproduction of TGF-beta1 and loss of TGFbeta-RII expression are associated with poor clinical outcome in prostate cancer, and TGF-beta1 may promote tumor progression by stimulating angiogenesis and metastasis.

References

44